GH Research Announces Closing of $125 Million Oversubscribed Series B Financing
Marijuana Stocks, Finance, & InvestingUncategorized April 14, 2021
Ireland-based GH Research has just raised $125 million in an oversubscribed Series B financing round.
Read more
Psychedelic Drugs: The Cure For ‘COVID Isolation Syndrome’?
Marijuana Stocks, Finance, & InvestingUncategorized April 14, 2021
A recent study shows HALF of all adults already experiencing anxiety due to the social isolation from COVID-19 lockdowns. COVID Isolation Syndrome.
Read more
MINDCURE (CSE: MCUR | OTC: MCURF) Announces The Addition Of Daniel Herrera, A Pharmaceutical Industry Executive With Specific Experience In Medical Psychoactive Segment
Marijuana Stocks, Finance, & InvestingUncategorized April 14, 2021
Mr. Herrera, Who Will Join The Company As Its Vice President Of Growth And Strategic Partnerships, Has 15+ Years Of Global Life Sciences Experience And Will Help To Drive MINDCURE’s Commercial Focus And Strategic Partnerships
Read more
Uber Will ‘Absolutely’ Explore Marijuana Deliveries When Federal Prohibition Ends, CEO Says Uber Will ‘Absolutely’ Explore Marijuana Deliveries When Federal Prohibition Ends, CEO Says
Marijuana Stocks, Finance, & Investing April 14, 2021 0
Uber Will ‘Absolutely’ Explore Marijuana Deliveries When Federal Prohibition Ends, CEO Says
The CEO of Uber said on Monday that the ride share company will “absolutely” explore adding marijuana deliveries to its services when federal prohibition ends.
How Cannabis Became the Gateway Drug…For Psychedelic Drug Normalization
Marijuana Stocks, Finance, & InvestingUncategorized April 13, 2021
Forty years ago, cannabis was labelled “a Gateway Drug” to harder drug use — such as psychedelics. Today, cannabis is the Gateway Drug to psychedelics legalization.
Read more
A woman cured her chronic skin itching with weed and didn’t need her steroid medications anymore, case report shows
Marijuana Stocks, Finance, & InvestingUncategorized April 13, 2021
A 60-something woman with skin so itchy it caused her to scratch until she created lesions finally found relief from using cannabis.
Read more
Peter Thiel-Backed Psychedelics Firm Buys Majority of Brain-Control Interface Firm
Marijuana Stocks, Finance, & InvestingUncategorized April 13, 2021
ATAI Life Sciences, a biosciences company backed by venture capitalist and freedom-loving billionaire Peter Thiel that specializes in experimental treatment of mental disorders with psychedelic drugs, has bought out a majority stake in a company working to meld the mind with machines.
Read more
The Mental Health Crisis: A Pandemic Becomes A Catastrophe
Marijuana Stocks, Finance, & InvestingUncategorized April 9, 2021
Two pandemics are currently afflicting the planet. While our governments focus on the smaller one (COVID-19), the larger one (the Mental Health Crisis) is rapidly spiralling out of control.
Read more
Case report: Consumption of psilocybin-containing mushrooms results in amelioration of OCD symptoms
Marijuana Stocks, Finance, & InvestingUncategorized April 9, 2021
Approximately 2.3% of adults will suffer from symptoms of Obsessive-Compulsive Disorder at some point in their life.
Read more
Psychedelic Stocks Primed For atai-MindMed Bounce
Marijuana Stocks, Finance, & InvestingUncategorized April 8, 2021
Both the atai Life Sciences IPO and a MindMed uplisting to the NASDAQ are highly anticipated events. They could occur within weeks — or even days — of each other.
Read more
